AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

Premier Path Wealth Partners, LLC's Holding History (CIK: 0001999925)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 20,265 Value ($000) $245 Avg Close $13.58 Range $11.69 - $16.96

Q3 2025

Shares 20,265 Value ($000) $275 Avg Close $9.41 Range $5.97 - $15.14

Q2 2025

Shares 20,265 Value ($000) $130 Avg Close $4.86 Range $3.11 - $6.70

Q1 2025

Shares 20,265 Value ($000) $72 Avg Close $3.56 Range $2.60 - $4.18

Q3 2024

Shares 20,265 Value ($000) $66 Avg Close $2.25 Range $1.62 - $3.33

Q1 2024

Shares 20,265 Value ($000) $58 Avg Close $13.08 Range $2.67 - $19.95

Q4 2023

Shares 20,265 Value ($000) $298 Avg Close $15.33 Range $11.82 - $18.88

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	20,265	$245	$13.58	$11.69 - $16.96
Q3 2025	20,265	$275	$9.41	$5.97 - $15.14
Q2 2025	20,265	$130	$4.86	$3.11 - $6.70
Q1 2025	20,265	$72	$3.56	$2.60 - $4.18
Q3 2024	20,265	$66	$2.25	$1.62 - $3.33
Q1 2024	20,265	$58	$13.08	$2.67 - $19.95
Q4 2023	20,265	$298	$15.33	$11.82 - $18.88